» Articles » PMID: 31164134

Association of Serum Bone- and Muscle-derived Factors with Age, Sex, Body Composition, and Physical Function in Community-dwelling Middle-aged and Elderly Adults: a Cross-sectional Study

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2019 Jun 6
PMID 31164134
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Understanding interactions between bone and muscle based on endocrine factors may help elucidate the relationship between osteoporosis and sarcopenia. However, whether the abundance or activity of these endocrine factors is affected by age and sex or whether these factors play a causal role in bone and muscle formation and function is unclear. We aimed to evaluate the association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults.

Methods: In all, 254 residents (97 men, 157 women) participated in this cross-sectional study conducted in Japan. The calcaneal speed of sound (SOS) was evaluated by quantitative ultrasound examination. Skeletal muscle mass index (SMI) was calculated by bioelectrical impedance analysis. Grip strength was measured using a dynamometer. Gait speed was measured by optical-sensitive gait analysis. Serum sclerostin, osteocalcin (OC), insulin-like growth factor-1 (IGF-1), myostatin, and tartrate-resistant acid phosphatase-5b (TRACP-5b) concentrations were measured simultaneously. The difference by sex was determined using t test. Correlations between serum bone- and muscle-derived factors and age, BMI, SOS, SMI, grip strength, gait speed, and TRACP-5b in men and women were determined based on Pearson's correlation coefficients. Multiple regression analysis was performed using the stepwise method.

Results: There was no significant difference with regard to age between men (75.0 ± 8.9 years) and women (73.6 ± 8.1 years). Sclerostin was significantly higher in men than in women and tended to increase with age in men; it was significantly associated with SOS and TRACP-5b levels. OC was significantly higher in women than in men and was significantly associated with TRACP-5b levels and age. IGF-1 tended to decrease with age in both sexes and was significantly associated with SOS and body mass index. Myostatin did not correlate with any assessed variables.

Conclusions: Sclerostin was significantly associated with sex, age, and bone metabolism, although there was no discernable relationship between serum sclerostin levels and muscle function. There was no obvious relationship between OC and muscle parameters. This study suggests that IGF-1 is an important modulator of muscle mass and function and bone metabolism in community-dwelling middle-aged and elderly adults.

Citing Articles

Causal associations between the insulin-like growth factor family and sarcopenia: a bidirectional Mendelian randomization study.

Liu J, Chen M, Xia X, Wang Z, Wang Y, Xi L Front Endocrinol (Lausanne). 2024; 15:1422472.

PMID: 39507055 PMC: 11537870. DOI: 10.3389/fendo.2024.1422472.


Evaluation of Serum Myostatin Concentration in Chronic Heart Failure with Preserved and Impaired Left Ventricular Ejection Fraction.

Baczek J, Charkiewicz M, Kasiukiewicz A, Witkowska A, Magnuszewski L, Baczek M J Clin Med. 2024; 13(6).

PMID: 38541967 PMC: 10971596. DOI: 10.3390/jcm13061741.


Sclerostin: clinical insights in muscle-bone crosstalk.

Moretti A, Iolascon G J Int Med Res. 2023; 51(8):3000605231193293.

PMID: 37632438 PMC: 10467411. DOI: 10.1177/03000605231193293.


Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.

Hagino H, Moriwaki K, Wada T, Osaki M, Nagashima H, Matsumoto H Osteoporos Int. 2023; 34(10):1703-1709.

PMID: 37291359 DOI: 10.1007/s00198-023-06816-5.


Risk factors of osteoporosis in elderly inpatients: A cross-sectional single-centre study.

Li H, Sun T, Han D, Gong W, Mao W, Gan X Front Aging. 2023; 4:1126172.

PMID: 37229241 PMC: 10204113. DOI: 10.3389/fragi.2023.1126172.


References
1.
Lee A, Hodges S, Eastell R . Measurement of osteocalcin. Ann Clin Biochem. 2000; 37 ( Pt 4):432-46. DOI: 10.1177/000456320003700402. View

2.
Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M . Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab. 2002; 284(3):E481-7. DOI: 10.1152/ajpendo.00319.2002. View

3.
Yarasheski K, Bhasin S, Sinha-Hikim I, Gonzalez-Cadavid N . Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging. 2002; 6(5):343-8. View

4.
Lewiecki E, Watts N . New guidelines for the prevention and treatment of osteoporosis. South Med J. 2009; 102(2):175-9. DOI: 10.1097/SMJ.0b013e31818be99b. View

5.
Morissette M, Stricker J, Rosenberg M, Buranasombati C, Levitan E, Mittleman M . Effects of myostatin deletion in aging mice. Aging Cell. 2009; 8(5):573-83. PMC: 2764272. DOI: 10.1111/j.1474-9726.2009.00508.x. View